Innovative Genetic Approach to Treating Depression and Anxiety скачать в хорошем качестве

Innovative Genetic Approach to Treating Depression and Anxiety

Welcome to Science Hub! Today, we’re diving into an exciting development in the treatment of depression and anxiety. For many, finding the right medication can be a frustrating journey of trial and error. But a new genetic approach might soon change that. Researchers from Germany, Sweden, and Denmark are pioneering a genetic method that could help doctors predict which antidepressants or anti-anxiety medications will work best for individual patients. This innovative technique relies on what’s known as polygenic risk scores. By analyzing a person’s DNA, these scores evaluate how genetic variations could influence their response to specific medications. While still in the research phase, this genetic testing shows promise. It has been tested against genetic research databases with encouraging results. The team, led by Professor Fredrik Ahs from Mid Sweden University, is hopeful that clinical trials will soon follow. Ahs envisions a future where this technology enables more targeted testing, ultimately allowing doctors to select the most effective treatment from the start. The project began two years ago when Ahs collaborated with Professor Doug Speed from Aarhus University in Denmark. Speed has spent years refining techniques to analyze complex genetic data, particularly concerning mental health disorders. Since the early twenty-first century, scientists have identified thousands of tiny variations in DNA that can impact health. Humans have about twenty thousand genes, each with multiple versions that can increase the risk of certain diseases. Researchers compile this genetic information into polygenic risk scores, which aggregate the effects of numerous genetic variations to assess the likelihood of developing specific conditions. Ahs and his team applied these scores to data from the Swedish Twin Registry. This allowed them to compare the effects of genes and environment on health and behavior. They discovered that medications like benzodiazepines and antihistamines were less effective in individuals with high genetic risk scores for depression or anxiety. While the study's results are promising, there are limitations, such as incomplete data on why patients change medications. The team is eager to conduct follow-up clinical studies to enhance the accuracy of their findings. Despite the need for further research, these results hint at a future where choosing antidepressants doesn’t rely on guesswork. A simple genetic test could one day help doctors match patients with the most effective treatment right from the start, saving time, reducing side effects, and improving the lives of millions worldwide. Thank you for watching Science Hub. If you enjoyed this video, don't forget to subscribe for more fascinating science insights!